bpc 157 safety review human data BPC-157 and the Difference Between an Evidence Gap and a Cover-Up: What the entire evidence base actually looks like, and the questions to ask next. — WellFounded Multifunctionality and Possible Medical Application
Description
Additionally, BPC 157 did not demonstrate any genetic or embryo-fetal toxicity during safety evaluations, ensuring that it does not pose significant risks to genetic integrity or fetal development

Ovarian Hyperstimulation Syndrome (OHSS) Ovarian Hyperstimulation Syndrome (OHSS) is a serious risk with hormone injections

12 pounds per week (68 pounds per month) , though results depend on factors like adherence, activity level, and metabolism

We can't stress this enough: technique is everything
